Armistice Capital’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Sell |
336,000
-4,000
| -1% | -$21.2K | 0.03% | 133 |
|
|
2025
Q1 | $2.63M | Buy |
340,000
+68,000
| +25% | +$527K | 0.04% | 133 |
|
|
2024
Q4 | $3.6M | Hold |
272,000
| – | – | 0.05% | 125 |
|
|
2024
Q3 | $2.72M | Sell |
272,000
-85,440
| -24% | -$853K | 0.04% | 146 |
|
|
2024
Q2 | $7.97M | Buy |
357,440
+40,000
| +13% | +$892K | 0.1% | 96 |
|
|
2024
Q1 | $18.6M | Sell |
317,440
-73,120
| -19% | -$4.3M | 0.25% | 68 |
|
|
2023
Q4 | $8.65M | Buy |
390,560
+74,880
| +24% | +$1.66M | 0.12% | 93 |
|
|
2023
Q3 | $6.81M | Buy |
315,680
+141,440
| +81% | +$3.05M | 0.1% | 98 |
|
|
2023
Q2 | $11.8M | Buy |
174,240
+81,760
| +88% | +$5.52M | 0.17% | 81 |
|
|
2023
Q1 | $43.1M | Sell |
92,480
-62,080
| -40% | -$29M | 0.62% | 35 |
|
|
2022
Q4 | $61.9M | Sell |
154,560
-23,680
| -13% | -$9.48M | 1.08% | 22 |
|
|
2022
Q3 | $58M | Buy |
178,240
+14,560
| +9% | +$4.74M | 1.01% | 23 |
|
|
2022
Q2 | $43.2K | Buy |
+163,680
| New | +$43.2K | 0.75% | 35 |
|